All News

The use of the treatment results in promising a response rate in patients with heavily pretreated RRMM, according to a presentation at the 2022 ASCO Annual Meeting.

Congress expected the FDA to draft a memorandum of understanding on interstate distributions of compounded medications that states would be willing to sign, but that’s not what the agency did.

Pharmacists know that even the slightest delay in delivering critical medications can interrupt patient therapy schedules, negatively impact lives, and translate to millions of dollars in business losses

The coexistence of hepatitis B virus (HBV) surface antigens and antibodies against are an atypical serological profile for patients with chronic HBV infections.

Teriparatide injection (Forteo) is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture or in patients who have failed or are intolerant to other available osteoporosis therapy.

D-Mannose can aid in maintaining urinary and bladder health.

Now we must turn our focus to all recommended vaccinations.

A patient with CLL relies on his pharmacy team for support.

Areas for improvement include the business model, health care team buy-in, patient engagement, and technology.

Social determinants of health (SDOH), which include social, economic, and physical conditions, have a major impact on people’s health, wellbeing, and quality of life.

Glycosite-specific antibody‒drug conjugates (gsADCs), harnessing Asn297 N-glycan of IgG Fc as the conjugation site for drug payloads, usually require multi-step glycoengineering with 2 or more enzymes, which limits the substrate diversification and complicates the preparation process.

It is the role of the pharmacist to ensure patients are adequately counseled on the adverse effects and potential harms of codeine.

The topical therapy demonstrated significant improvements in the study, based on IGA success and other endpoints, according to investigators.

PrEP therapy has revolutionized HIV treatment by protecting patients who are high risk for acquiring the virus.

Risankizumab-rzaa (Skyrizi) is the first and only specific interleukin-23 inhibitor approved for the treatment of adults with moderately to severely active Crohn disease.

Contrave is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults.

Uqora Target flushes the urinary tract to help avoid urinary tract infections.

The treatment gives patients with neovascular age-related macular degeneration a more affordable option, the companies say.

The role of the pharmacist in sickle cell disease management revolves around appropriate pain management.

The study has met its primary endpoint, with approximately 78.4% of women who continued taking the drug achieving the sustained responder rate through week 76.

Anna Pham, PharmD, PGY2 ambulatory care resident at Intermountain Healthcare, discusses the role of ambulatory care pharmacists in primary care clinics.

Since the COVID-19 pandemic began, more than 10.6 million children have tested positive for the virus in the United States.

The drug is being evaluated as the first potential allogeneic advanced cell therapy donor source for patients with blood cancers in need of a transplant.

Utilization of the RAPID3 tool can be a beneficial way for pharmacists to complete disease activity assessments without physically seeing the patient in a clinic setting.

The ATHENA-MONO trial is investigating the use of rucaparib as front line maintenance treatment in ovarian cancer.

Biosimilar therapeutic interchange processes can mitigate high costs of cancer drugs.

Selpercatinib (Retevmo, Loxo Oncology) is FDA-approved to treat 3 types of tumors—metastatic RET fusion-positive non-small cell lung cancer, advanced medullary thyroid cancer (MTC) or MTC that has spread, and advanced RET fusion-positive thyroid cancer.

Jim Gilligan, PhD, discusses a phase 2 study investigating psilocybin-assisted therapy for binge eating disorder.